Novosanis

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests as well as the accuracy of drug delivery for infectious diseases and oncology. Novosanis currently has two devices (platforms) in portfolio: VAX-ID, suited for accurate intradermal injections and Colli-Pee, suited for standardized and volumetric collection of first void (first catch) urine.
Company Type:
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Belgium
Year Founded:
Not Provided
Main Therapeutic Focus:
Lead Product in Development:
Colli-Pee Small Volumes
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
CEO
Novosanis